Announcing Peplogue: The First Free Guide That Grades Peptides on Evidence and Shows the Law in Different Countries

Valmiera, Latvia–(Newsfile Corp. – October 26, 2026) – Peptides have become one of the most talked-about topics in health, from the weight-loss drugs semaglutide and tirzepatide to unapproved products such as BPC-157 sold online. The information people find is split between dense regulator pages and sellers with something to gain. SIA LearnBetter today launched Peplogue, a free, noncommercial guide that puts the evidence, the risks and the law for each peptide on one page, in English, Spanish,…